Baseline | Follow-up | |||||
---|---|---|---|---|---|---|
Intervention | Control | Total | Intervention | Control | Total | |
Prevalence n/N (%; range between shehias) | 31/4042 (0.8; 0.0–1.6) | 95/3875 (2.5; 0.7–4.5) | 126/7917 (1.6; 0.0–4.5) | 82/4896 (1.7; 0.5–3.9) | 71/4905 (1.4; 0.5–4.0) | 153/9801 (1.6, 0.5–4.0) |
Prevalence without travel history n/N (%; range between shehias) | 28/4042 (0.7; 0.0–1.6) | 90/3875 (2.3; 0.7–4.5) | 118/7917 (1.5; 0.0–5.0) | 79/4896 (1.6; 0.6–3.9) | 68/4905 (1.4; 0.5–4.1) | 147/9801 (1.5;0.5–4.0) |
Malaria species | ||||||
P. falciparum (N; %) | 22; 71.0% | 64; 67.4% | 86; 68.3% | 61; 74.4% | 47; 66.2% | 108; 70.6% |
P. malariae (N; %) | 2; 6.5% | 17; 17.9% | 19; 15.1% | 7; 8.5% | 11; 15.5% | 18; 11.8% |
P. ovale (N; %) | 4; 12.9% | 1; 1.1% | 5; 4.0% | 5; 6.1% | 7; 9.9% | 12; 7.8% |
P. vivax (N; %) | 1; 3.2% | 0; 0.0% | 1; 0.8% | 1; 1.2% | 0; 0.0% | 1; 0.7 |
Mixed infections (N; %)1 | 2; 6.5% | 12; 12.6% | 14; 11.1% | 6; 7.3% | 6; 8.5% | 12; 7.8% |
Undetermined (N; %) | 0; 0.0% | 1; 1.1% | 1; 0.8% | 2; 2.4% | 0; 0.0% | 2; 1.3% |
Parasite densities | ||||||
Geometric mean p/μL [IQR]2 | 8 [2–21] | 8 [< 1–50] | 8 [< 1–43] | 11 [< 1–57] | 3 [< 1–21] | 6 [< 1–35] |
Samples <LLOQ (N; %)3 | 6; 19.4% | 29; 30.5% | 35; 27.8% | 43; 52.4% | 30; 42.2% | 73; 47.7% |